相关实验视频
Updated: Jan 11, 2026

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
7.0K
作为强大的ASK1抑制剂的皮拉佐洛皮里丁衍生物:设计,合成和生物评估
Hao Liu1, Xiaorui Han1, Mike Hu2
1College of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, PR China.
Bioorganic chemistry
|November 9, 2025
概括
研究人员开发了一种新型化合物,化合物20,作为非酒精性脂肪肝炎 (NASH) 的潜在治疗方法. 这种新药有效抑制ASK1,并在临床前模型中显示出有前途的安全性.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 非酒精性脂肪肝炎 (NASH) 缺乏有效的治疗方法,鉴定出亡信号调节激酶1 (ASK1) 是主要的治疗标.
- 现有的NASH治疗方法有限,需要开发新型治疗剂.
研究的目的:
- 为NASH治疗设计和合成基于pyrazolopyridine的新型ASK1抑制剂.
- 为了确定有效的ASK1抑制的关键药理片段,并评估化合物20作为主要候选物.
主要方法:
- 基于结构的药物设计,使用GS-4997作为参考.
- 通过化环循环化和亚环循环修饰合成pyrazolopyridine衍生物.
- 在NASH细胞模型中进行ASK1抑制,细胞毒性和脂质积累的体外试验.
- 机械学研究涉及西方涂抹和分子对接.
主要成果:
- 化合物20显示出强大的ASK1抑制 (IC50 = 6.3nM),与GS-4997.7相比.
- 化合物20在测试度下表现出良好的安全性,对LO2细胞没有显著的细胞毒性.
- 在FFA诱导的NASH模型中,化合物20降低了脂质积累和关键代谢标记物 (T-CHO,TG,LDL-C).
- 化合物20有效抑制了ASK1-p38/JNK通路的激活,并降低了p-ASK1/ASK1比率.
结论:
- 化合物20是NASH治疗的非常有前途的领先候选人,显示出强大的ASK1抑制和良好的安全性.
- 确定的药理特征对于开发有效的ASK1抑制剂至关重要.
- 对20化合物进行进一步的研究是有必要的,因为它在NASH中具有治疗潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K

